White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus

Not recruiting

1 1 1 1
Investigated Drugs:
Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

Not recruiting

1 1 1
Investigated Drugs:
- Tazemetostat
Study on Intravenous Ferric Carboxymaltose for Preoperative Anemia in Patients with Lower Limb Peripheral Artery Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Anaemia
Investigated Drugs:
- Ferric Carboxymaltose
Study on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis

Not recruiting

2 1
Investigated Diseases:
- Hepatitis alcoholic
Investigated Drugs:
- Int-787
Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents

Not recruiting

4 1 1
Investigated Drugs:
- Imetelstat Sodium
+2
Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis

Not recruiting

2 1
Investigated Diseases:
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Fipaxalparant
Study on the Effects of Psilocybin for Patients with Psychogenic Non-Epileptic Seizures (PNES)

Not recruiting

2 1 1
Investigated Diseases:
- Psychogenic seizure
- Seizure
Investigated Drugs:
- Psilocybine
Study on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients

Not recruiting

4 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Nelarabine
- Zirconium (89Zr) Crefmirlimab Berdoxam
Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

Not recruiting

2 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
- Glenzocimab
- Gadobutrol
Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Golimumab
- Guselkumab
+14

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies